Ontario medical regulator pauses safer supply drug changes after legal challenge
Ontario’s medical regulator is pausing implementation of changes to how doctors prescribe safer supply drugs after it was served with a legal challenge.
The College of Physicians and Surgeons of Ontario is pausing enforcement of new safer supply prescription rules after being served with a legal challenge including an injunction motion.

Ontario’s medical regulator is pausing implementation of changes to how doctors prescribe safer supply drugs after it was served with a legal challenge.
The College of Physicians and Surgeons of Ontario says it was served Friday with the legal action, which includes a motion for an injunction to prevent the regulator from enforcing the new safer supply rules. The changes were set to come into effect on Monday, but the college says it is pausing enforcement to allow time to respond to the injunction.
The college approved sweeping changes to the safer supply prescription regime last month that would require doctors to prescribe safer supply drugs only in conjunction with opioid agonist therapy. Safer supply drugs are medications given to people at high risk of overdose as an alternative to illicit opioids, while opioid agonist therapy uses medications such as Suboxone and methadone to treat opioid addiction.
The new rules would also require patients to take their safer supply medications in front of health-care professionals, rather than take them home — a change that has raised accessibility concerns especially for patients in rural Ontario and those who work regular hours.
The medical regulator has said the changes were approved in an effort to reduce the amount of opioids prescribed as safer supply drugs making their way to the streets. The chair of the regulator’s board, Dr. Patrick Safieh, has said police forces in Ontario are noticing patients’ safer supply drugs being diverted to the black market.
The pause means the new prescribing rules will not be enforced on Monday as planned, leaving the current safer supply framework in place while the legal challenge proceeds.
Sources
This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.
The day's checked news, by email
One short email a day with the top stories. Free, and you can unsubscribe in one click.
Or follow for the latest news:
No comments yet. Start the discussion.
A panel of independent experts convened by the Pan American Health Organization has ruled that the United States no longer meets the criteria for measles elimination, according to reports citing anonymous sources. The PAHO director must still rule on the recommendation.
Novo Nordisk says its Wegovy injection significantly lowered body mass index in children ages 6 to under 12 with obesity in a late-stage trial, with no safety concerns related to growth or pubertal development.